Novel media formulations to enhance Chimeric Antigen Receptor (CAR) T-cell potency and anti-tumor cell function for adoptive immunotherapy

被引：0
|
作者：
Ghassemi, S. [1 ,2 ]
Martinez-Becerra, F. [3 ]
Master, A.
Richman, S. A. [1 ,4 ,5 ]
Heo, D. [1 ,2 ]
Leferovich, J. [1 ,2 ]
Tu, Y. [1 ,8 ]
Garcia-Canaveras, J. C. [6 ]
Ayari, A. [3 ]
Lu, Y. [1 ,2 ]
Wang, A. [1 ,2 ]
Rabinowitz, J. D. [6 ,7 ]
Milone, M. C. [1 ,2 ]
O'Connor, R. [1 ,2 ]
机构：
[1] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA
[2] Univ Penn, Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Nucleus Biol, San Diego, CA USA
[4] Childrens Hosp Philadelphia, Pediat Oncol, Philadelphia, PA 19104 USA
[5] Perelman Sch Med, Philadelphia, PA USA
[6] Princeton Univ, Chem, Princeton, NJ 08544 USA
[7] Princeton Univ, Lewis Singer Integrat Genom, Princeton, NJ 08544 USA
[8] Univ Penn, Biol Phys, Princeton, NJ USA
来源：
CYTOTHERAPY | 2020年 / 22卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
257
引用
收藏
页码：S133 / S133
页数：1
相关论文
共 50 条
  • [21] An easy way to make a good anti-tumor chimeric antigen receptor T cell?
    Muranski, Pawel
    CYTOTHERAPY, 2014, 16 (05) : 577 - 578
  • [22] Adoptive T cell immunotherapy using chimeric antigen receptor against a novel cancer target Axl
    Intisar, Ejaj
    Walsh, Anthony
    Weinberg, Benjamin
    Chakravarti, Deboki
    Wong, Wilson
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [23] OVEREXPRESSING CAR T-CELL GLUCOSE TRANSPORTER TO ENHANCE ANTI-TUMOR ACTIVITY IN GLIOBLASTOMA
    Sengupta, Srabasti
    Jin, Linchun
    Feier, Diana
    Silver, Aryeh
    Chakraborty, Avirup
    Tao, Haipeng
    Thomas, Nagheme
    Rahman, Maryam
    Flores, Catherine
    Castillo, Paul
    Sarkisian, Matthew
    Huang, Jianping
    Mitchell, Duane A.
    Deleyrolle, Loic P.
    NEURO-ONCOLOGY, 2024, 26
  • [24] Chimeric Antigen Receptor (CAR) T Cell Immunotherapy for Poor Risk Sarcomas
    Huang, Xin
    Greene, Joseph
    Pao, James
    Mulvey, Erin
    Zhou, Sophia X.
    Sachdev, Deepali
    Yee, Douglas
    Rader, Christoph
    Albert, Catherine M.
    Park, Haein
    Chu, Yaya
    Hamby, Carl
    Loeb, David
    Cairo, Mitchell S.
    Zhou, Xianzheng
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S184 - S185
  • [25] Humoral Immunity and Plasma Cell Changes in Patients Responding to CD19-Specific Chimeric Antigen Receptor (CAR)-Modified T-Cell Adoptive Immunotherapy
    Bhoj, Vijay
    Milone, Michael C.
    June, Carl H.
    Porter, David
    Grupp, Stephan A.
    Melenhorst, Jan J.
    Lacey, Simon F.
    Callahan, Colleen
    Capobianchi, James
    Wertheim, Gerald
    Mahnke, Yolanda
    BLOOD, 2014, 124 (21)
  • [26] Chimeric Antigen Receptor (CAR) T-cell Therapy in Neurological Disorders
    Habib, Ali
    Ciurea, Stefan
    Kamboh, Hafsa
    Miljkovic, Milos
    Mozaffar, Tahseen
    NEUROLOGY, 2024, 103 (07) : S119 - S120
  • [27] Infectious complications of chimeric antigen receptor (CAR) T-cell therapies
    Gea-Banacloche, Juan C.
    SEMINARS IN HEMATOLOGY, 2023, 60 (01) : 52 - 58
  • [28] Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies
    Kiesgen, Stefan
    Chicaybam, Leonardo
    Chintala, Navin K.
    Adusumilli, Prasad S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (01) : 16 - 26
  • [29] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [30] T-cell Immunotherapy and Cardiovascular Disease Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies
    Stein-Merlob, Ashley F.
    Ganatra, Sarju
    Yang, Eric H.
    HEART FAILURE CLINICS, 2022, 18 (03) : 443 - 454
12345